Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03515538
Title Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors EpicentRx, Inc.
Indications

oropharynx cancer

oral squamous cell carcinoma

Therapies

Cisplatin + RRx-001

RRx-001

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
John Wayne Cancer Institute @ Providence St. John's Health Center Santa Monica California 90401 United States Details
Centura Health Research Center Denver Colorado 80210 United States Details
George Washington University Washington District of Columbia 20037 United States Details
Florida Hospital Orlando Florida 32804 United States Details
Montefiore Medical Center Bronx New York 10467 United States Details
East Carolina University Greenville North Carolina 27834 United States Details
University of Cincinnati Medical Center Cincinnati Ohio 45267 United States Details
Ohio State University Columbus Ohio 43210 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
Ballad Health Johnson City Tennessee 37604 United States Details
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 United States Details
UT Southwestern Dallas Texas 75390 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field